Transition from adenocarcinoma in situ to invasive adenocarcinoma then to large cell lung carcinoma with rhabdoid phenotype , immunohistochemical and molecular findings ; case report and literature review

Xiaoyong Zheng,O. Ardacheva,C. Puccio,J. Fallon,Liying Han
Abstract:Background: Current cancer therapy of non-small cell lung cancer depends on histopathological classification. Large cell lung carcinoma with rhabdoid phenotype (LCC-RP) is a rare type of lung cancer with poor prognosis. Methodology and principal findings: This is a case of a 64-year-old male patient with a lung mass composed of adenocarcinoma in situ (AIS), invasive adenocarcinoma with acinar predominant pattern and LCC-RP. The tumor consisted of 10% AIS, 30% invasive adenocarcinoma with acinar predominant pattern and 60% solid tumor with rhabdoid phenotype. Immunohistochemical study showed that all three components expressed thyroid transcription factor-1 (TTF-1), pan-cytokeratin AE1/3 and epithelial membrane antigen (EMA). In the transition areas from AIS to rhabdoid phenotype, the tumor cells expressed less TTF-1 and napsin A, completely lost E-cadherin expression and expressed the mesenchymal marker Vimentin. Molecular testing showed that both the adenocarcinoma and rhabdoid components had the same mutation Gly13Asp (GGC->GAC) in KRAS and no EGFR mutations or ALK gene rearrangements. Conclusion: These findings suggest that LCC-RP is not an entity by itself but a dedifferentiated adenocarcinoma undergoing epithelial-to-mesenchymal transition (EMT).
What problem does this paper attempt to address?